|
|
|
|
| DZ141A |
Apolipoprotein A-I assay (immunoturbidimetric) (Dual vial liquid stable) |
| DZ142A |
Apolipoprotein B assay (immunoturbidimetric) (Dual vial liquid stable) |
| DZ143A |
Cholesterol, Total (CHOD-PAP) (Dual vial liquid stable) |
| DZ129A |
HDL-Cholesterol assay (PVS\PEGME coupled) (Dual vial liquid stable) |
| DZ568A |
Homocysteine assay (enzymatic) (Three vial liquid stable) |
| DZ568B |
Homocysteine assay (enzymatic) (Dual vial liquid stable) |
| DZ568B |
Homocysteine assay for SMART POC Analyzer |
| DZ128A |
LDL-Cholesterol assay (PVS\PEGME coupled) (Dual vial liquid stable) |
| DZ131A |
Lipoprotein Lp(a) (immunoturbidimetric) (Dual vial liquid stable) |
| DZ144A |
Triglycerides assay (GPO-PAP) (Dual vial liquid stable) |
|
|
|
| DZ168A |
Direct Enzymatic HbA1c assay, Single channel (liquid stable) |
| DZ168B |
Direct Enzymatic HbA1c for SMART POC Analyzer |
| DZ112A |
Fructosamine assay (enzymatic) (Glycated Serum Protein) (Dual vial powder & diluent) |
|
| Renal And Pancreatic Disease |
|
| DZ072B |
Creatinine assay (enzymatic) (Dual vial liquid stable) |
| DZ133C |
Cystatin C assay (immunoturbidimetric) (Dual vial liquid stable) |
| DZ132A |
Lipase assay (Dual vial liquid stable) |
| DZ062A |
(NAG) assay N-acetyl-b-D-glucosaminidase (Three vial liquid stable) |
|
|
|
| DZ123A |
5¡¯- Nucleotidase assay (Dual vial liquid stable) |
| DZ117A |
Adenosine Deaminase (ADA) assay (Dual vial liquid stable) |
| DZ082B |
a-L-fucosidase (AFU) assay (Single vial liquid stable) |
| DZ151A |
Bilirubin Direct assay (vanadate) (Dual vial liquid stable) |
| DZ150A |
Bilirubin Total assay (vanadate) (Dual vial liquid stable) |
| DZ042A |
Total Bile Acids assay (enzyme cycling method) (Dual vial liquid stable) |
| DZ092A |
Total Bile Acids assay (NBT method) (Dual vial, stable liquid + powder & diluent) |
|
|
|
| DZ122A |
Carbon Dioxide (CO2) assay (enzymatic 405 nm) (Single vial liquid stable) |
| DZ200A |
Chloride assay (enzymatic) (Dual vial liquid stable) |
| DZ116B |
Lithium Assay (enzymatic) (Dual vial liquid stable) |
| DZ113C |
Potassium Assay (enzymatic) (Dual vial liquid stable) |
| DZ114B |
Sodium Assay (enzymatic) (Dual vial liquid stable) |
|
|
|
| DZ135A |
hsCRP assay (immunoturbimetric) (Dual vial liquid) |
|
|
|
| DZ688A |
25-Hydroxy Vitamin D (DBP based, enzymatic) |
|
| ǰ ¸í |
Cat. ¹øÈ£ |
ÀÎÁõ |
ÃøÁ¤ |
| Ƚ¼ö |
¹üÀ§ |
½Ã·á |
Data Sheet |
|
| 25-Hydroxy Vitamin D |
DZ688A |
CE, FDA |
Ãø Á¤ |
| 96 |
5 ~ 125 ng/mL |
S. P. |
|
| Ãø Á¤ ½Ã °£ : 2½Ã°£ À̳» ( Colorimetric ) |
|
| 5¡¯-Nucleotidase (5¡¯-NT) Enzymatic Test Kit |
DZ123A |
FDA |
Ãø Á¤ |
| 96 |
0 ~ 300 U/L |
S |
|
| Ãø Á¤ ½Ã °£ : 2½Ã°£ À̳» ( Colorimetric ) |
|
| Apolipoprotein A-I (Apo A-I) assay kit |
DZ141A |
CE, FDA |
Ãø Á¤ |
| 1120 |
1.44 - 250 mg/dL |
S. |
|
| Ãø Á¤ : turbidimetrically at 340 nm (Immunoturbidometric) |
|
| Apolipoprotein B assay assay kit |
DZ142A |
CE, FDA |
Ãø Á¤ |
| 1120 |
3.6 - 242 mg/dL |
S. P. |
|
| Ãø Á¤ : turbidimetrically at 340 nm (Immunoturbidometric) |
|
| Bilirubin Total assay(vanadate) assay kit |
DZ150A |
FDA |
Ãø Á¤ |
| 900 |
0.1 - 40 mg/dL |
S. P. |
|
|
| Bilirubin Direct assay kit |
DZ151A |
FDA |
Ãø Á¤ |
| 900 |
0.1 - 40 mg/dL |
S. P. |
|
|
| Carbon Dioxide (CO2) assay |
DZ122A |
CE, FDA |
Ãø Á¤ |
| 300 |
|
S. P. |
|
| Ãø Á¤ : Colorimetric/Kinetic |
|
| Creatinine Assay (enzymatic) |
DZ072A |
CE, FDA |
Ãø Á¤ |
| 200 |
|
S. P. U. |
|
| Ãø Á¤ : Colorimetric, endpoint |
|
| Cystatin C Assay |
DZ133C |
CE, FDA |
Ãø Á¤ |
| 360 |
0 ~ 8mg/dl |
S. P. U. |
|
| Ãø Á¤ : Immunoturbidity Assay |
|
| Direct Enzymatic HbA1c assay |
DZ168A |
CE, FDA |
Ãø Á¤ |
| 90 |
|
blood |
|
| Ãø Á¤ : Enzymatic, endpoint |
|
| Glycated Serum Protein (Glycated Albumin) |
DZ112B |
CE, FDA |
Ãø Á¤ |
| 180 |
21mM ~ 1354mM/L |
S |
|
| Ãø Á¤ : Colorimetric, endpoint |
|
| HDL-Cholesterol |
DZ129A |
CE, FDA |
Ãø Á¤ |
| 1120 |
1.1mg ~ 184.8mg/dL |
S , P |
|
| Ãø Á¤ : Modified PVS/PEGME |
|
Homocysteine assay (enzymatic) (Three vial liquid stable) |
DZ568A |
CE, FDA |
Ãø Á¤ |
| 190 |
3 ~ 50uM/L |
S , P |
|
|
Homocysteine assay (enzymatic) (Dual vial liquid stable) |
DZ568B |
CE, FDA |
Ãø Á¤ |
| 190 |
3 ~ 50uM/L |
S , P |
|
|
| hsCRP Assay |
DZ135A |
CE, FDA |
Ãø Á¤ |
| 200 |
0.2 ~ 20mg/L |
S , P |
|
| Ãø Á¤ : Turbidimetric Immunoassay |
|
| LDL-Cholesterol |
DZ128A |
CE, FDA |
Ãø Á¤ |
| 1120 |
4.0 ~ 232.0 mg/L |
S , P |
|
|
| Lipase Assay |
DZ132A |
CE, FDA |
Ãø Á¤ |
| 300 |
|
S , P |
|
|
| Lipoprotein(a) [Lp(a)] |
DZ131A |
CE |
Ãø Á¤ |
| 300 |
5.21 ~ 94.83 mg/ml |
S , P(EDTA) |
|
|
| Lithium (Enzymatic) Assay (Liquid Stable) |
DZ116B |
CE, FDA |
Ãø Á¤ |
| 200 |
0.1 ~ 3.1 mM/ml |
S , P |
|
| Ãø Á¤ : Enzymatic/Kinetic |
|
| Potassium assay |
DZ113C |
FDA |
Ãø Á¤ |
| 720 |
2.0 ~ 8.0mM/ml |
S , P |
|
|
| Sodium assay |
DZ114B |
CE, FDA |
Ãø Á¤ |
| 720 |
184.0 ~ 414.0 mg/ml |
S , P |
|
| Ãø Á¤ : Enzymatic/Kinetic |
|
| Total Bile Acids assay |
DZ042A |
CE, FDA |
Ãø Á¤ |
| 400 |
1.0 ~ 180 uM/ml |
S |
|
| Ãø Á¤ : Enzymatic, endpoint |
|